José L. Orgaz

2.5k total citations
26 papers, 1.6k citations indexed

About

José L. Orgaz is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, José L. Orgaz has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cell Biology and 11 papers in Oncology. Recurrent topics in José L. Orgaz's work include Cellular Mechanics and Interactions (8 papers), Cell Adhesion Molecules Research (7 papers) and Melanoma and MAPK Pathways (6 papers). José L. Orgaz is often cited by papers focused on Cellular Mechanics and Interactions (8 papers), Cell Adhesion Molecules Research (7 papers) and Melanoma and MAPK Pathways (6 papers). José L. Orgaz collaborates with scholars based in Spain, United Kingdom and United States. José L. Orgaz's co-authors include Victoria Sanz‐Moreno, Pahini Pandya, Cecilia Herráiz, Óscar Maiques, Benilde Jiménez, Irene Rodríguez‐Hernández, Sophia N. Karagiannis, Gaia Cantelli, Eva Crosas‐Molist and Panagiotis Karagiannis and has published in prestigious journals such as Nature Communications, Physiological Reviews and The Journal of Cell Biology.

In The Last Decade

José L. Orgaz

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José L. Orgaz Spain 20 938 544 462 320 180 26 1.6k
Ana Cerezo Spain 13 1.1k 1.1× 841 1.5× 677 1.5× 358 1.1× 170 0.9× 16 2.0k
Andrei Turtoï France 27 1.1k 1.2× 580 1.1× 240 0.5× 483 1.5× 312 1.7× 64 1.9k
Matthew Holderfield United States 17 1.7k 1.8× 564 1.0× 281 0.6× 266 0.8× 219 1.2× 25 2.2k
Christine Tan United States 10 1.2k 1.2× 487 0.9× 187 0.4× 243 0.8× 318 1.8× 17 1.9k
Dora Cavallo‐Medved Canada 21 601 0.6× 437 0.8× 230 0.5× 564 1.8× 134 0.7× 37 1.3k
Isabel Chu United States 11 1.1k 1.2× 1.0k 1.9× 267 0.6× 346 1.1× 135 0.8× 12 1.8k
Roya Navab Canada 25 1.1k 1.1× 694 1.3× 237 0.5× 638 2.0× 211 1.2× 46 2.0k
Remedios Castelló-Cros United States 12 1.2k 1.3× 614 1.1× 300 0.6× 1.1k 3.3× 157 0.9× 12 1.9k
Julie Pannequin France 21 945 1.0× 590 1.1× 167 0.4× 344 1.1× 120 0.7× 46 1.7k
Carl O. Postenka Canada 22 778 0.8× 785 1.4× 202 0.4× 459 1.4× 94 0.5× 27 1.6k

Countries citing papers authored by José L. Orgaz

Since Specialization
Citations

This map shows the geographic impact of José L. Orgaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José L. Orgaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José L. Orgaz more than expected).

Fields of papers citing papers by José L. Orgaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José L. Orgaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José L. Orgaz. The network helps show where José L. Orgaz may publish in the future.

Co-authorship network of co-authors of José L. Orgaz

This figure shows the co-authorship network connecting the top 25 collaborators of José L. Orgaz. A scholar is included among the top collaborators of José L. Orgaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José L. Orgaz. José L. Orgaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maiques, Óscar, Bruce Fanshawe, Eva Crosas‐Molist, et al.. (2021). A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma. British Journal of Cancer. 125(5). 699–713. 14 indexed citations
2.
Crosas‐Molist, Eva, Rémi Samain, José L. Orgaz, et al.. (2021). Rho GTPase signaling in cancer progression and dissemination. Physiological Reviews. 102(1). 455–510. 149 indexed citations
3.
Rodríguez‐Hernández, Irene, Óscar Maiques, Gaia Cantelli, et al.. (2020). WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion. Nature Communications. 11(1). 5315–5315. 64 indexed citations
4.
Farrugia, Aaron J., Javier Rodríguez, José L. Orgaz, et al.. (2020). CDC42EP5/BORG3 modulates SEPT9 to promote actomyosin function, migration, and invasion. The Journal of Cell Biology. 219(9). 45 indexed citations
5.
Orgaz, José L., Eva Crosas‐Molist, Amine Sadok, et al.. (2020). Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance. Cancer Cell. 37(1). 85–103.e9. 96 indexed citations
6.
Pandya, Pahini, José L. Orgaz, & Victoria Sanz‐Moreno. (2017). Actomyosin contractility and collective migration: may the force be with you. Current Opinion in Cell Biology. 48. 87–96. 86 indexed citations
7.
Herráiz, Cecilia, Fernando Calvo, Pahini Pandya, et al.. (2015). Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination. JNCI Journal of the National Cancer Institute. 108(1). djv289–djv289. 154 indexed citations
8.
Cantelli, Gaia, José L. Orgaz, Irene Rodríguez‐Hernández, et al.. (2015). TGF-β-Induced Transcription Sustains Amoeboid Melanoma Migration and Dissemination. Current Biology. 25(22). 2899–2914. 88 indexed citations
9.
Orgaz, José L., Cecilia Herráiz, & Victoria Sanz‐Moreno. (2014). Rho GTPases modulate malignant transformation of tumor cells. Small GTPases. 5(4). e983867–e983867. 140 indexed citations
10.
Orgaz, José L., Pahini Pandya, Panagiotis Karagiannis, et al.. (2014). Diverse matrix metalloproteinase functions regulate cancer amoeboid migration. Nature Communications. 5(1). 4255–4255. 145 indexed citations
11.
Fernández‐Barral, Asunción, José L. Orgaz, Pablo Baquero, et al.. (2014). Regulatory and Functional Connection of Microphthalmia-Associated Transcription Factor and Anti-Metastatic Pigment Epithelium Derived Factor in Melanoma. Neoplasia. 16(6). 529–542. 23 indexed citations
12.
Baquero, Pablo, et al.. (2013). V600EBRAF promotes invasiveness of thyroid cancer cells by decreasing E-cadherin expression through a Snail-dependent mechanism. Cancer Letters. 335(1). 232–241. 49 indexed citations
13.
Orgaz, José L. & Victoria Sanz‐Moreno. (2012). Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell & Melanoma Research. 26(1). 39–57. 82 indexed citations
14.
Sánchez-Martı́nez, Cristina, et al.. (2011). Pigment Epithelium-Derived Factor Blocks Tumor Extravasation by Suppressing Amoeboid Morphology and Mesenchymal Proteolysis. Neoplasia. 13(7). 633–IN11. 42 indexed citations
15.
16.
Moncho-Amor, Verónica, Inmaculada Ibañez de Cáceres, Eva Bandrés, et al.. (2010). DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer. Oncogene. 30(6). 668–678. 88 indexed citations
17.
Moreno, Alberto, et al.. (2010). Functional impact of cancer-associated mutations in the tumor suppressor protein ING4. Carcinogenesis. 31(11). 1932–1938. 19 indexed citations
18.
Orgaz, José L., Keith S. Hoek, Asunción Fernández‐Barral, et al.. (2009). ‘Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma’. Oncogene. 28(47). 4147–4161. 60 indexed citations
19.
Cáceres, Inmaculada Ibañez de, Eva Bandrés, José L. Orgaz, et al.. (2008). Identification of DUSP1/MKP1 mediated pathways in lung cancer progression. European Journal of Cancer Supplements. 6(9). 69–70. 1 indexed citations
20.
Orgaz, José L., et al.. (2008). Following up tumour angiogenesis: from the basic laboratory to the clinic. Clinical & Translational Oncology. 10(8). 468–477. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Cerezo Breakdown of academic impact, for papers by Andrei Turtoï Breakdown of academic impact, for papers by Matthew Holderfield Breakdown of academic impact, for papers by Christine Tan Breakdown of academic impact, for papers by Dora Cavallo‐Medved Breakdown of academic impact, for papers by Isabel Chu Breakdown of academic impact, for papers by Roya Navab Breakdown of academic impact, for papers by Remedios Castelló-Cros Breakdown of academic impact, for papers by Julie Pannequin Breakdown of academic impact, for papers by Carl O. Postenka
Rankless by CCL
2026